Form 4 for NEPH NEPHROS INC

Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-17 · accession 0000914190-21-000282 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-08-18	2021-08-17+	NEPH	Astor Andrew	Pres, CEO, Dir	P - Purchase	$7.72	+5,000	78.0K	+7%	+$38.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-08-17	P	A	2,500	$7.67	75,458	D	—	—	(F1) The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.66 to $7.6699. The reporting person undertakes to provide the Company, any security holder of the Company. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
2	Common	Common Stock	2021-08-18	P	A	2,500	$7.77	77,958	D	—	—	(F2) The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.60 to $7.85. The reporting person undertakes to provide the Company, any security holder of the Company. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.